Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China flag China · Delayed Price · Currency is CNY
14.95
-0.70 (-4.47%)
Sep 10, 2026, 2:40 PM CST

SHE:300401 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,2781,2201,2211,0821,3971,107
Other Revenue
15.8917.722.4512.9320.399.75
1,2941,2371,2431,0951,4181,117
Revenue Growth
1.23%-0.47%13.58%-22.78%26.89%69.40%
Cost of Revenue
652.6555.88519.59441.4486.37350.66
Gross Profit
641.55681.52723.7653.25931.14766.44
Selling, General & Admin
196.09234.8308.87378.77444.55257.61
Research & Development
78.3165.4683.7890.9170.3459.28
Other Operating Expenses
25.818.5113.2416.4416.243.48
Operating Expenses
301.72320.89407.84483.74533.66320.69
Operating Income
339.83360.63315.86169.51397.48445.75
Interest Expense
-32.18-32.47-35.63-38.41-21.82-10.81
Interest & Investment Income
10.799.6411.0120.5413.7532.49
Currency Exchange Gain (Loss)
-17.44-1.926.317.0211.1-2.79
Other Non Operating Income (Expenses)
-6.21-0.69-0.35-0.3-0.65-0.19
EBT Excluding Unusual Items
294.79335.19297.19158.36399.86464.46
Gain (Loss) on Sale of Investments
2.273.770.25-0.34-2.830.4
Gain (Loss) on Sale of Assets
-2.19-2.2431.53-0.0417.876.22
Asset Writedown
-3.94-3.98-0.44-0.22-1.01-0.09
Other Unusual Items
25.5819.7630.1753.2728.6748.38
Pretax Income
316.51352.5358.69211.04442.48589.37
Income Tax Expense
41.2847.6449.4818.758.7675.42
Earnings From Continuing Operations
275.24304.86309.21192.35383.72513.94
Minority Interest in Earnings
0.010.010---30.18
Net Income
275.24304.86309.21192.35383.72483.77
Net Income to Common
275.24304.86309.21192.35383.72483.77
Net Income Growth
-16.25%-1.41%60.76%-49.87%-20.68%83.79%
Shares Outstanding (Basic)
550544542550548544
Shares Outstanding (Diluted)
596598595601548544
Shares Change
3.82%0.53%-1.07%9.65%0.85%7.38%
EPS (Basic)
0.500.560.570.350.700.89
EPS (Diluted)
0.460.510.520.320.700.89
EPS Growth
-19.33%-1.92%62.50%-54.29%-21.35%71.15%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
108.41112.78-13.97-84.57-2.89-203.33
Free Cash Flow Per Share
0.180.19-0.02-0.14-0.01-0.37
Dividend Per Share
0.1130.1130.1140.0710.1400.188
Dividend Growth
-0.88%-0.88%60.56%-49.29%-25.53%82.52%
Gross Margin
49.57%55.08%58.21%59.68%65.69%68.61%
Operating Margin
26.26%29.14%25.41%15.48%28.04%39.90%
Profit Margin
21.27%24.64%24.87%17.57%27.07%43.31%
Free Cash Flow Margin
8.38%9.11%-1.12%-7.72%-0.20%-18.20%
EBITDA
522.98538.72471.63302.82458.27490.2
EBITDA Margin
40.41%43.54%37.93%27.66%32.33%43.88%
D&A For EBITDA
183.16178.09155.77133.3160.7944.45
EBIT
339.83360.63315.86169.51397.48445.75
EBIT Margin
26.26%29.14%25.41%15.48%28.04%39.90%
Effective Tax Rate
13.04%13.52%13.80%8.86%13.28%12.80%
Revenue as Reported
1,2941,2371,2431,0951,4181,117
Advertising Expenses
-3.112.370.970.70.8